{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:11:30Z","timestamp":1787638290891,"version":"build-2736575974"},"reference-count":42,"publisher":"Begell House","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Crit Rev Eukaryot Gene Expr"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Parkinson's disease (PD) is a progressive neurodegenerative disease. This study aims to investigate the role of discoidin, CUB and LCCL domain containing 1 (DCBLD1) in PD. GSE156926 is used to analyze the differentially expressed genes in PD patients. 1-Methyl-4-phenylpyridinium (MPP+) is used to establish &lt;i&gt;in vitro&lt;\/i&gt; PD models. mRNA expression is detected using quantitative reverse transcriptase PCR (qRT-PCR). Protein expression is determined using Western blot. LC3 puncta expression is detected using immunofluorescence assay. Cell viability is detected using Cell Counting Kit-8 (CCK-8) assay. Neuronal apoptosis is determined using flow cytometry and terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay. We found that DCBLD1 is downregulated in PD, which induces neuronal apoptosis and autophagy inhibition. Interestingly, overexpressed DCBLD1 inhibits neuronal apoptosis as well as restores autophagy and neuronal function. Moreover, DCBLD1 mediates the upregulation of transcription factor EB (TFEB). However, TFEB knockdown-induced autophagy inhibition alleviates the effects of DCBLD1 and contributes to neuronal apoptosis. In summary, DCBLD1 protects against neuronal apoptosis in PD via activating TFEB. Therefore, targeting DCBLD1\/TFEB axis may be a promising strategy for PD.<\/p>","DOI":"10.1615\/critreveukaryotgeneexpr.2025060535","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T16:42:47Z","timestamp":1757004167000},"page":"1-10","source":"Crossref","is-referenced-by-count":1,"title":["DCBLD1 Inhibits the Progression of Parkinson\u00e2\u0080\u0099s Disease by Regulating Apoptosis and Autophagy"],"prefix":"10.1615","volume":"35","author":[{"given":"Jianmei","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maicang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson's disease. Lancet Neurol. 2021;20:385-97.","DOI":"10.1016\/S1474-4422(21)00030-2"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Tanner CM, Ostrem JL. Parkinson's disease. N Engl J Med. 2024;391:442-52.","DOI":"10.1056\/NEJMra2401857"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Ye H, Robak LA, Yu M, Cykowski M, Shulman JM. Genetics and pathogenesis of Parkinson's syndrome. Annu Rev Pathol. 2023;18:95-121.","DOI":"10.1146\/annurev-pathmechdis-031521-034145"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Leite Silva ABR, Gon\u00e7alves de Oliveira RW, Di\u00f3genes GP, de Castro Aguiar MF, Sallem CC, Lima MPP, de Albuquerque Filho LB, Peixoto de Medeiros SD, Penido de Mendonca LL, de Santiago Filho PC, Nones DP, da Silva Cardoso PMM, Ribas MZ, Galv\u00e3o SL, Gomes GF, Bezerra de Menezes AR, Dos Santos NL, Moror\u00f3 VM, Duarte FS, Dos Santos JCC. Premotor, nonmotor and motor symptoms of Parkinson's disease: A new clinical state of the art. Ageing Res Rev. 2023;84:101834.","DOI":"10.1016\/j.arr.2022.101834"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Vijiaratnam N, Simuni T, Bandmann O, Morris HR, Foltynie T. Progress towards therapies for disease modification in Parkinson's disease. Lancet Neurol. 2021;20:559-72.","DOI":"10.1016\/S1474-4422(21)00061-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Gui M, Lv L, Hu S, Qin L, Wang C. Sarcopenia in Parkinson's disease: From pathogenesis to interventions. Metabolism. 2025;169:156272.","DOI":"10.1016\/j.metabol.2025.156272"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Kalyanaraman B, Cheng G, Hardy M. Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS\/RNS: Relevance to Parkinson's disease and therapeutic implications. Redox Biol. 2024;71: 103092.","DOI":"10.1016\/j.redox.2024.103092"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Yaribash S, Mohammadi K, Sani MA. Alpha-synuclein pathophysiology in neurodegenerative disorders: A review focusing on molecular mechanisms and treatment advances in Parkinson's disease. Cell Mol Neurobiol. 2025;45:30.","DOI":"10.1007\/s10571-025-01544-2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Kamath T, Abdulraouf A, Burris SJ, Langlieb J, Gazestani V, Nadaf NM, Balderrama K, Vanderburg C, Macosko EZ. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson's disease. Nat Neurosci. 2022;25:588\u00e2\u0080\u009395.","DOI":"10.1038\/s41593-022-01061-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Lal R, Singh A, Watts S, Chopra K. Experimental models of Parkinson's disease: Challenges and opportunities. Eur J Pharmacol. 2024;980:176819.","DOI":"10.1016\/j.ejphar.2024.176819"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Coukos R, Krainc D. Key genes and convergent pathogenic mechanisms in Parkinson disease. Nat Rev Neurosci. 2024;25:393-413.","DOI":"10.1038\/s41583-024-00812-2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Levine B, Kroemer G. Biological functions of autophagy genes: A disease perspective. Cell. 2019;176:11-42.","DOI":"10.1016\/j.cell.2018.09.048"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Ornatowski W, Lu Q, Yegambaram M, Garcia AE, Zemskov EA, Maltepe E, Fineman JR, Wang T, Black SM. Complex interplay between autophagy and oxidative stress in the development of pulmonary disease. Redox Biol. 2020;36:101679.","DOI":"10.1016\/j.redox.2020.101679"},{"key":"15","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Virgilio L, Silva-Lucero MD, Flores-Morelos DS, Gallardo-Nieto J, Lopez-Toledo G, Abarca-Fernandez AM, Zacapala-G\u00f3mez AE, Luna-Mu\u00f1oz J, Montiel-Sosa F, Soto-Rojas LO, Pacheco-Herrero M, Cardenas-Aguayo MD. Autophagy: A key regulator of homeostasis and disease: An overview of molecular mechanisms and modulators. Cells. 2022;11(15):2262.","DOI":"10.3390\/cells11152262"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Zhang Y, Wu Q, Zhang L, Wang Q, Yang Z, Liu J, Feng L. Caffeic acid reduces A53T alpha-synuclein by activating JNK\/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease. Pharmacol Res. 2019;150:104538.","DOI":"10.1016\/j.phrs.2019.104538"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Nguyen M, Wong YC, Ysselstein D, Severino A, Krainc D. Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson's disease. Trends Neurosci. 2019;42:140-9.","DOI":"10.1016\/j.tins.2018.11.001"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Chen D, Pang S, Feng X, Huang W, Hawley RG, Yan B. Genetic analysis of the ATG7 gene promoter in sporadic Parkinson's disease. Neurosci Lett. 2013;534:193-8.","DOI":"10.1016\/j.neulet.2012.12.039"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Han R, Liu Y, Li S, Li XJ, Yang W. PINK1-PRKN mediated mitophagy: Differences between in vitro and in vivo models. Autophagy. 2023;19:1396-405.","DOI":"10.1080\/15548627.2022.2139080"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Yuan J, Liu H, Zhang H, Wang T, Zheng Q, Li Z. Controlled activation of TRPV1 channels on microglia to boost their autophagy for clearance of alpha-synuclein and enhance therapy of Parkinson's disease. Adv Mater. 2022;34:e2108435.","DOI":"10.1002\/adma.202108435"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Promtang S, Sanguanphun T, Chalorak P, Pe LS, Niamnont N, Sobhon P, Meemon K. 2-butoxytetrahydrofuran, isolated from holothuria scabra, attenuates aggregative and oxidative properties of alpha-synuclein and alleviates its toxicity in a transgenic caenorhabditis elegans model of Parkinson's disease. ACS Chem Neurosci. 2024;15:2182-97.","DOI":"10.1021\/acschemneuro.4c00008"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Zhu J, Xu F, Lai H, Yuan H, Li XY, Hu J, Li W, Liu L, Wang C. ACO2 deficiency increases vulnerability to Parkinson's disease via dysregulating mitochondrial function and histone acetylation-mediated transcription of autophagy genes. Commun Biol. 2023;6:1201.","DOI":"10.1038\/s42003-023-05570-y"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Prasertsuksri P, Kraokaew P, Pranweerapaiboon K, Sobhon P, Chaithirayanon K. Neuroprotection of andrographolide against neurotoxin MPP(+)-induced apoptosis in SH-SY5Y cells via activating mitophagy, autophagy, and antioxidant activities. Int J Mol Sci. 2023;24(10):8528.","DOI":"10.3390\/ijms24108528"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Wu LK, Agarwal S, Kuo CH, Kung YL, Day CH, Lin PY, Lin SZ, Hsieh DJ, Huang CY, Chiang CY. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy\/mitophagy clearance in both in vitro and in vivo models of MPP+\/MPTP-induced Parkinson's disease. Phytomedicine. 2022;104:154250.","DOI":"10.1016\/j.phymed.2022.154250"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Huang YB, Tian LL, Zhu ZW, Zhou KG, Lai X, Peng YZ, Wu Z, Tong WF, Wang H, Wang XJ, Guan Q, Jin LJ, Feng Y, Weng WY, Zhang JX. Apigenin enhances Nrf2-induced chaperone-mediated autophagy and mitigates alpha-synuclein pathology: Implications for Parkinson's disease therapy. Phytomedicine. 2025;141:156652.","DOI":"10.1016\/j.phymed.2025.156652"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Fu LL, Yan M, Ma MX, Luo Y, Shao M, Gosau M, Friedrich RE, Vollkommer T, Feng HC, Smeets R. DCBLD1 overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma. Front Immunol. 2022;13:939344.","DOI":"10.3389\/fimmu.2022.1099835"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Sherva R, Zhang R, Sahelijo N, Jun G, Anglin T, Chanfreau C, Cho K, Fonda JR, Gaziano JM, Harrington KM, Ho YL, Kremen WS, Litkowski E, Lynch J, Neale Z, Roussos P, Marra D, Mez J, Miller MW, Salat DH, Tsuang D, Wolf E, Zeng Q, Panizzon MS, Merritt VC, Farrer LA, Hauger RL, Logue MW. African ancestry GWAS of dementia in a large military cohort identifies significant risk loci. Mol Psych. 2023;28:1293-302.","DOI":"10.1038\/s41380-022-01890-3"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Nartey MN, Pena-Castillo L, LeGrow M, Dore J, Bhattacharya S, Darby-King A, Carew SJ, Yuan Q, Harley CW, McLean JH. Learning-induced mRNA alterations in olfactory bulb mitral cells in neonatal rats. Learn Mem. 2020;27:209-21.","DOI":"10.1101\/lm.051177.119"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Pluta R. The dual role of autophagy in postischemic brain neurodegeneration of Alzheimer's disease Proteinopathy. Int J Mol Sci. 2023;24(18):13793.","DOI":"10.3390\/ijms241813793"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Saadh MJ, Faisal A, Adil M, Zabibah RS, Mamadaliev AM, Jawad MJ, Alsaikhan F, Farhood B. Parkinson's Disease and microRNAs: A duel between inhibition and stimulation of apoptosis in neuronal cells. Mol Neurobiol. 2024;61:8552-74.","DOI":"10.1007\/s12035-024-04111-w"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Park H, Kam TI, Peng H, Chou SC, Mehrabani-Tabari AA, Song JJ, Yin X, Karuppagounder SS, Umanah GK, Rao AVS, Choi Y, Aggarwal A, Chang S, Kim H, Byun J, Liu JO, Dawson TM, Dawson VL. PAAN\/MIF nuclease inhibition prevents neurodegeneration in Parkinson's disease. Cell. 2022;185:1943-59.e1921.","DOI":"10.1016\/j.cell.2022.04.020"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Kim TW, Koo SY, Riessland M, Chaudhry F, Kolisnyk B, Cho HS, Russo MV, Saurat N, Mehta S, Garippa R, Betel D, Studer L. TNF-NF-kappaB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons. Cell. 2024;187:3671-89.e3623.","DOI":"10.1016\/j.cell.2024.05.030"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Xu F, Bian N, Li X. SNHG14 Elevates NFAT5 Expression Through Sequestering miR-375-3p to promote MPP + -induced neuronal apoptosis, inflammation, and oxidative stress in Parkinson's disease. Neurochem Res. 2024;49:1212-25.","DOI":"10.1007\/s11064-024-04106-y"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Garcia JPT, Tayo LL. Codes between poles: Linking transcriptomic insights into the neurobiology of bipolar disorder. Biology. 2024;13(10):787.","DOI":"10.3390\/biology13100787"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Shen Z, Li M, Zhu H, Song T. TBP activates DCBLD1 transcription to promote cell cycle progression in cervical cancer. Funct Integr Genom. 2024;24:221.","DOI":"10.1007\/s10142-024-01496-8"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Nixon RA, Rubinsztein DC. Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases. Nat Rev Mol Cell Biol. 2024;25:926-46.","DOI":"10.1038\/s41580-024-00757-5"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Wu J, Xu W, Su Y, Wang GH, Ma JJ. Targeting chaperone-mediated autophagy in neurodegenerative diseases: Mechanisms and therapeutic potential. Acta Pharmacol Sin. 2025;46:816-28.","DOI":"10.1038\/s41401-024-01416-3"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Prieto Huarcaya S, Drobny A, Marques ARA, Di Spiezio A, Dobert JP, Balta D, Werner C, Rizo T, Gallwitz L, Bub S, Stojkovska I, Belur NR, Fogh J, Mazzulli JR, Xiang W, Fulzele A, Dejung M, Sauer M, Winner B, Rose-John S, Arnold P, Saftig P, Zunke F. Recombinant pro-CTSD (cathepsin D) enhances SNCA\/alpha-Synuclein degradation in alpha-Synucleinopathy models. Autophagy. 2022;18:1127-51.","DOI":"10.1080\/15548627.2022.2045534"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Guan XJ, Deng ZQ, Liu J, Su CF, Tong BC, Zhu Z, Sreenivasmurthy SG, Kan YX, Lu KJ, Chu CP, Pi RB, Cheung KH, Iyaswamy A, Song JX, Li M. Corynoxine promotes TFEB\/TFE3-mediated autophagy and alleviates Abeta pathology in Alzheimer's disease models. Acta Pharmacol Sin. 2024;45:900-13.","DOI":"10.1038\/s41401-023-01197-1"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Lu J, Su P, Zhao F, Yu K, Yang X, Lv H, Wang D, Zhang J. The role of TFEB-mediated autophagy-lysosome dysfunction in manganese neurotoxicity. Curr Res Toxicol. 2024;7:100193.","DOI":"10.1016\/j.crtox.2024.100193"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Zhang K, Zhu S, Li J, Jiang T, Feng L, Pei J, Wang G, Ouyang L, Liu B. Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease. Acta Pharm Sin B. 2021;11:3015-34.","DOI":"10.1016\/j.apsb.2021.02.016"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Chen J, Mao K, Yu H, Wen Y, She H, Zhang H, Liu L, Li M, Li W, Zou F. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease. J Neuroinflamm. 2021;18:295.","DOI":"10.1186\/s12974-021-02349-y"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Ramalingam M, Jeong HS, Hwang J, Cho HH, Kim BC, Kim E, Jang S. Autophagy signaling by neural-induced human adipose tissue-derived stem cell-conditioned medium during rotenone-induced toxicity in SH-SY5Y cells. Int J Mol Sci. 2022;23(8):4193.","DOI":"10.3390\/ijms23084193"}],"container-title":["Critical Reviews in Eukaryotic Gene Expression"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/46c9fcc64ba56a63\/CRE-60535.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T07:57:42Z","timestamp":1765958262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/6dbf508d3b17c437,22b25596365788b3,46c9fcc64ba56a63.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/critreveukaryotgeneexpr.2025060535","relation":{},"ISSN":["1045-4403"],"issn-type":[{"value":"1045-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}